| escitalopram / Generic mfg. |
NCT00648570: Fasting Study of Escitalopram Oxalate Tablets 20 mg and Lexapro® Tablets 20 mg |
|
|
| Completed | 1 | 37 | US | Escitalopram Oxalate Tablets 20 mg, Lexapro® Tablets (20 mg | Mylan Pharmaceuticals Inc | Healthy | 10/04 | 10/04 | | |
NCT00648661: Food Study of Escitalopram Oxalate Tablets 20 mg to Lexapro® Tablets 20 mg |
|
|
| Completed | 1 | 35 | US | Escitalopram Oxalate Tablets 20 mg, Lexapro® Tablets 20 mg | Mylan Pharmaceuticals Inc | Healthy | 10/04 | 10/04 | | |
NCT00361790: Aripiprazole and Lexapro Drug Interaction Study |
|
|
| Completed | 1 | 25 | US | Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg, Abilify | Otsuka Pharmaceutical Development & Commercialization, Inc. | Healthy | 11/06 | 11/06 | | |
NCT00414323: Evaluation of the Effects of Duloxetine on Norepinephrine |
|
|
| Completed | 1 | 35 | US | Duloxetine, Escitalopram, Placebo | Eli Lilly and Company | Major Depressive Disorder | | 05/07 | | |
NCT01996462: Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fasting Condition |
|
|
| Completed | 1 | | RoW | Escitalopram Oxalate Tablets | Torrent Pharmaceuticals Limited | Healthy | 05/08 | | | |
NCT01996475: Bioequivalence Study of Torrent Pharmaceutical Ltd.'s of Escitalopram Oxalate Tablets Under Fed Condition |
|
|
| Completed | 1 | | RoW | Escitalopram Oxalate Tablets | Torrent Pharmaceuticals Limited | Healthy | 05/08 | | | |
NCT00933894: VX-950-TiDP24-C133 - A Phase I Study Investigating the Interaction Between Telaprevir and Escitalopram |
|
|
| Completed | 1 | 16 | RoW | Telaprevir; Escitalopram | Tibotec BVBA | Hepatitis C | 11/09 | 11/09 | | |
NCT01395433: Bioequivalence Study Comparing Two Formulations of Escitalopram |
|
|
| Completed | 1 | 32 | Europe | Escitalopram | H. Lundbeck A/S | Healthy | 03/10 | | | |
NCT01745601: Bioequivalence Study of Escitalopram Tablets 10 mg |
|
|
| Completed | 1 | 26 | NA | escitalopram 10 mg, Lexapro® LUNDBECK MEXICO SA de CV, escitalopram GLAXOSMITHKLINE MEXICO SA de CV | GlaxoSmithKline | Anxiety Disorders | 05/10 | 05/10 | | |
NCT01090700: TMC435-TiDP16-C112 - Interaction Trial With Antidepressants |
|
|
| Completed | 1 | 20 | Europe | TMC435, Escitalopram, TMC435 + Escitalopram | Tibotec Pharmaceuticals, Ireland | Hepatitis C Virus | 09/10 | 09/10 | | |
NCT01045083: A Study of the Ability of Functional Magnetic Resonance Imaging (fMRI) to Detect and Characterize the Effects of Two Marketed Centrally Active Drugs, Placebo, and RO4917523 in Healthy Volunteers |
|
|
| Completed | 1 | 25 | US | RO4917523, escitalopram, Lexapro, methylphenidate, Ritalin, placebo | Hoffmann-La Roche | Healthy Volunteer | 06/11 | 06/11 | | |
NCT01418274: A Study to Evaluate the Effect of Danoprevir/Ritonavir on the Pharmacokinetics of Escitalopram and S-Demethylcitalopram in Healthy Volunteers |
|
|
| Completed | 1 | 20 | US | danoprevir, escitalopram, ritonavir | Hoffmann-La Roche | Healthy Volunteer | 09/11 | 09/11 | | |
| Unknown status | 1 | 30 | Canada | Cipralex®, Chemical/Pharmaceutical alternative name: Escitalopram | University of Ottawa, H. Lundbeck A/S | Anxiety Disorder | 01/12 | 01/12 | | |
NCT02175602: Study of Drug Combination on Pharmacokinetics in Healthy Volunteers |
|
|
| Completed | 1 | 41 | US | Escitalopram, Lexapro, Sertraline, Zoloft, DCV 3DAA FDC, BMS-791325 | Bristol-Myers Squibb | Hepatitis C Infection | 08/14 | | | |
NCT02072278: Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects |
|
|
| Completed | 1 | 32 | Europe | Vortioxetine 10 mg, Vortioxetine 20 mg, Escitalopram 15 mg, Placebo | H. Lundbeck A/S | Healthy Men | 11/14 | | | |
NCT06476509: A Study to Assess Serotonin Transporter Occupancy of Healthy Adults Using 11C-DASB PET |
|
|
| Not yet recruiting | 1 | 8 | NA | LV232 40mg, LV232, Escitalopram 20 mg, Escitalopram | Vigonvita Life Sciences | Major Depressive Disorder | 09/24 | 10/24 | | |
